NL-OMON31376尚未招募不适用
Een gerandomiseerde placebo gecontroleerde studie naar de toegevoegde waarde van D-cycloserine aan exposure therapie bij pati??nten met een poststraumatische stress stoornis - D-cycloserine in exposure treatment for PTSD
GGZ Nijmegen (Nijmegen)0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Inclusion criteria are (1) age between 18 and 65 and (2) current DSM-IV diagnosis of PTSD established with a structured diagnostic interview (M.I.N.I. and CAPS).
排除标准
- •Diagnostic exclusion criteria are (1) psychosis or delusion disorders (current or in the past) (2) suicidality (3) mental retardation (4) substance abuse or dependence or alcohol abuse of dependence, as established by a structured diagnostic interview (M.I.N.I.). Medical exclusion criteria are (1) pregnant or lactating women. Also women who are planning a pregnancy and don???t want to postpone a pregnancy during the treatment phase are excluded. According to the Informatorium Medicamentorum (2006), the influence of the use of D-cycloserine during pregnancy and breastfeeding is unknown. However, for safety reasons, we exclude these women. (2) patients who have a serious and unstable medical illness, as confirmed by their doctor, such as use of a pacemaker, renal disease or porfyrie (3) a history of epileptic seizures (4) medication use that may interfere with D-cycloserine, such as anticoagulants (5) patients who use antidepressants
研究者
相似试验
进行中（未招募）
不适用
Een gerandomiseerde placebo gecontroleerde studie naar de toegevoegde waarde van D-cycloserine aan exposure therapie bij patiënten met een poststraumatische stress stoornisEUCTR2007-003891-20-NLGGZ Nijmegen
尚未招募
1 期
A Randomized placebo clinical study and life style interventionon Mesha Shringyadi Gugglu in MedovridhhiCTRI/2016/03/006709IPGT and RA Gau Jamnagar40
进行中（未招募）
1 期
A study to quantify any differences in blood pressure control and kidney function after oral administration of amlodipine (a drug to treat high blood pressure) and celecoxib (a non steroidal anti inflammatory drug) given together or amlodipine alone, once daily, in adult patients with high blood pressure.HypertensionEUCTR2016-002214-47-GBKitov Pharmaceuticals Ltd105
进行中（未招募）
1 期
A study to quantify any differences in blood pressure control after oral administration of amlodipine (a drug to treat high blood pressure) and celecoxib (a non steroidal anti inflammatory drug) given together or alone, once daily, in adult patients with newly diagnosed hypertension.HypertensionEUCTR2013-005381-19-GBKitov Pharmaceuticals Ltd
招募中
1 期
MRI to monitor the effect of zoledronic acid in erosive psoriatic arthritisInflammatory and Immune System - Other inflammatory or immune system disordersPsoriatic arthritisACTRN12605000583640niversity of Auckland50